USV PRIVATE LTD (India) holds 31 active US FDA Type II Drug Master Files and 23 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 2 FDA-registered manufacturing sites. 29 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “USV PRIVATE LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/usv-private-ltd

Overview

USV PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 31 active FDA Type II Drug Master Files, covering ACITRETIN USP; BLENDED METFORMIN HCL; DAPAGLIFLOZIN (DAPAGLIFLOZIN 30% W/W SOLUTION IN ISOPROPYL ALCOHOL); DOLASETRON MESYLATE USP; DONEPEZIL HYDROCHLORIDE USP MONOHYDRATE; ELAGOLIX SODIUM.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which USV PRIVATE LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

USV PRIVATE LTD holds 31 active (54 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • ELAGOLIX SODIUMActive2024-09-30
  • EMPAGLIFLOZINActive2023-12-30
  • RIVAROXABAN USP (MICRONISED)Active2023-03-31
  • DAPAGLIFLOZIN (DAPAGLIFLOZIN 30% W/W SOLUTION IN ISOPROPYL ALCOHOL)Active2022-09-30
  • TICAGRELORActive2021-09-24
  • ETELCALCETIDE HYDROCHLORIDEActive2021-07-22
  • TRIMETAZIDINE DIHYDROCHLORIDEActive2021-03-30
  • SUGAMMADEX SODIUMActive2019-08-31
  • ICATIBANT ACETATEActive2018-12-07
  • DOLASETRON MESYLATE USPActive2018-09-28
  • PALONOSETRON HYDROCHLORIDEActive2015-09-29
  • REGADENOSONActive2015-06-23
  • NATEGLINIDE USP [MICRONISED]Active2013-03-25
  • OLOPATADINE HYDROCHLORIDE USPActive2011-01-31
  • ZOLEDRONIC ACID (MONOHYDRATE)Active2010-12-24
  • OCTREOTIDE ACETATE USPActive2010-11-01
  • ACITRETIN USPActive2009-12-10
  • NARATRIPTAN HYDROCHLORIDE USPActive2009-08-26
  • IMIQUIMOD USPActive2007-04-05
  • DONEPEZIL HYDROCHLORIDE USP MONOHYDRATEActive2006-03-24
  • PIOGLITAZONE HYDROCHLORIDE USP (EXTRA PURE)Active2006-03-10
  • ROPINIROLE HYDROCHLORIDE USPActive2005-12-19
  • REPAGLINIDE USPActive2005-05-09
  • METFORMIN HYDROCHLORIDE DC GRANULESActive2004-10-14
  • METFORMIN HYDROCHLORIDE USP (COARSE)Active2004-10-14
  • GLIMEPIRIDE USPActive2003-07-18
  • PIOGLITAZONE HYDROCHLORIDEActive2003-07-08
  • GLYBURIDE USPActive2002-01-24
  • BLENDED METFORMIN HCLActive2001-08-01
  • METFORMIN HCL USPActive1997-09-08
  • GLIPIZIDE USPActive1997-02-24
  • LINEZOLIDInactive2012-12-31
  • COLESEVELAM HYDROCHLORIDEInactive2012-03-20
  • SEVELAMER CARBONATEInactive2011-11-03
  • EPTIFIBATIDEInactive2011-07-26
  • DOLASETRON MESYLATE USPInactive2010-09-23
  • BEXAROTENEInactive2010-03-16
  • ATOVAQUONE USP (FORM I)Inactive2010-03-09
  • ATOVAQUONE USP (FORM III)Inactive2010-02-18
  • LETROZOLE USPInactive2008-12-09
  • ENTACAPONEInactive2008-11-21
  • SEVELAMER HYDROCHLORIDEInactive2008-11-04
  • CLOPIDOGREL BISULFATE USPInactive2008-10-24
  • ATOVAQUONE USPInactive2007-07-06
  • FLUVASTATIN SODIUM USPInactive2007-05-11
  • ANASTROZOLEInactive2007-03-14
  • DORZOLAMIDE HYDROCHLORIDE USPInactive2007-02-15
  • IRBESARTAN USPInactive2007-01-12
  • BICALUTAMIDEInactive2005-05-26
  • NIMODIPINE USPInactive2004-11-22

Showing the 50 most relevant of 54 Drug Master Files (active first). The full list is in the FDA DMF list.

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to USV PRIVATE LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

29 FDA enforcement records linked to this company.

  • warning_letter2026-11-02

    FDA Warning Letter (drug product)

  • recall — Class II2025-10-29

    Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.

  • 4832025-09-12

    Cleaning / Sanitizing / Maintenance

  • 4832022-11-17

    Validation lacking for sterile drug products

  • 4832022-11-17

    Procedure Deviations Recorded and Justified

  • 4832022-11-17

    Absence of Written Procedures

  • 4832022-11-17

    Investigations of discrepancies, failures

  • 4832022-11-17

    Procedures for sterile drug products

  • 4832022-11-17

    In-process materials specifications testing

  • 4832022-11-17

    Acceptance of drug products

  • 4832022-11-17

    Training , Education , Experience overall

  • 4832022-11-17

    Written program not followed

  • 4832022-11-17

    Lab controls established, including changes

  • 4832022-08-19

    Failure to develop written procedures

  • 4832017-08-02

    Establish reliability of supplier's C of A

  • 4832017-08-02

    Procedures for sterile drug products

  • 4832017-08-02

    Training , Education , Experience overall

  • 4832017-08-02

    Investigations of discrepancies, failures

  • 4832017-08-02

    Scientifically sound laboratory controls

  • warning_letter2017-03-10

    FDA Warning Letter (drug product)

  • 4832015-10-23

    Written record of investigation incomplete

  • 4832015-10-23

    Scientifically sound laboratory controls

  • 4832015-10-23

    Procedures not in writing, fully followed

  • 4832015-10-23

    Identification of Person Performing Review of Lab Records

  • 4832015-10-23

    Complete Test Data

  • warning_letter2014-02-06

    FDA Warning Letter (drug product)

  • 4832012-10-14

    Absence of Written Procedures

  • 4832012-10-14

    Extent of discrepancy, failure investigations

  • 4832012-10-14

    Cleaning / Sanitizing / Maintenance

For suppliers

Is this USV PRIVATE LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.